ENTA
Price
$11.65
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
68 days until earnings call
PLRX
Price
$12.60
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
48 days until earnings call
Ad is loading...

ENTA vs PLRX

Header iconENTA vs PLRX Comparison
Open Charts ENTA vs PLRXBanner chart's image
Enanta Pharmaceuticals
Price$11.65
Change-$0.00 (-0.00%)
Volume$94.99K
CapitalizationN/A
Pliant Therapeutics
Price$12.60
Change-$0.00 (-0.00%)
Volume$691.57K
CapitalizationN/A
View a ticker or compare two or three
ENTA vs PLRX Comparison Chart
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ENTA vs. PLRX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a Hold and PLRX is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (ENTA: $11.65 vs. PLRX: $12.60)
Brand notoriety: ENTA and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 65% vs. PLRX: 160%
Market capitalization -- ENTA: $246.85M vs. PLRX: $766.1M
ENTA [@Biotechnology] is valued at $246.85M. PLRX’s [@Biotechnology] market capitalization is $766.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTA is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 3 TA indicator(s) are bullish while PLRX’s TA Score has 3 bullish TA indicator(s).

  • ENTA’s TA Score: 3 bullish, 5 bearish.
  • PLRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ENTA and PLRX are a bad buy in the short-term.

Price Growth

ENTA (@Biotechnology) experienced а -3.88% price change this week, while PLRX (@Biotechnology) price change was -2.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

ENTA is expected to report earnings on Nov 25, 2024.

PLRX is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($766M) has a higher market cap than ENTA($247M). ENTA YTD gains are higher at: 23.804 vs. PLRX (-30.425). ENTA has higher annual earnings (EBITDA): -104.08M vs. PLRX (-181.41M). PLRX has more cash in the bank: 437M vs. ENTA (230M). ENTA has less debt than PLRX: ENTA (50.6M) vs PLRX (60.2M). ENTA has higher revenues than PLRX: ENTA (72M) vs PLRX (0).
ENTAPLRXENTA / PLRX
Capitalization247M766M32%
EBITDA-104.08M-181.41M57%
Gain YTD23.804-30.425-78%
P/E RatioN/AN/A-
Revenue72M0-
Total Cash230M437M53%
Total Debt50.6M60.2M84%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
73
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTAPLRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
70%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRGSX67.250.51
+0.76%
Neuberger Berman Genesis R6
GTSDX8.940.05
+0.56%
Invesco Small Cap Growth C
BRXUX13.950.03
+0.22%
MFS Blended Research Intl Eq R4
MIMFX13.20N/A
N/A
AMG Veritas China I
MAICX8.41-0.02
-0.24%
Victory Trivalent Intl Fd-Core Eq A

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with INZY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
-1.35%
INZY - ENTA
44%
Loosely correlated
-2.67%
VIR - ENTA
42%
Loosely correlated
+0.76%
DYN - ENTA
42%
Loosely correlated
+0.58%
ARWR - ENTA
41%
Loosely correlated
-2.15%
PRME - ENTA
41%
Loosely correlated
+6.95%
More